Effects of probucol on the composition and in vitro catabolism of LDL in type IIa hypercholesterolemia
- 1 October 1986
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 62 (1) , 65-71
- https://doi.org/10.1016/0021-9150(86)90020-1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemiaAtherosclerosis, 1985
- The hypolipidemic action of probucolAtherosclerosis, 1985
- The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemiaAtherosclerosis, 1982
- Metabolic studies with probucol in hypercholesterolaemiaAtherosclerosis, 1981
- Effects of probucol on low density lipoprotein removal and high density lipoprotein synthesisAtherosclerosis, 1981
- Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemiaMetabolism, 1980
- Probucol in hypercholesterolemia *1A double blind studyAtherosclerosis, 1980
- Effect of probucol in hyperlipidemic patients during two years of administrationAmerican Heart Journal, 1978
- Mode of action of a new hypocholesteraemic drug (DH-581) in familial hypercholesteraemiaAtherosclerosis, 1972
- Hypocholesterolesmic Effect of 4,4′-(Isopropylidenedithio)-Bis(2,6-di-t-Butylphenol) (Probucol)The American Journal of Clinical Nutrition, 1970